Novel anti-sense RNA approaches to treat neurological disease Francis Combes anchored at SINTEF, BTN is pioneering a novel anti-sense RNA approach to target various diseases of central nervous system. Following early characterization of these approaches, they will be tested for efficacy in Parkinson's disease model in collaboration with Hilde Nilsen, brain tumor model in collaboration with Deo Pandey and stroke/ischemia model in collaboration with Johanne Egge Rinholm.